文献速递神经MR

基于列线图策略识别低级别胶质瘤中IDH突变与ATRX表达缺失亚分类

A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas.
PubMed 文献 · Eur Radiol · 2022-02-08

本研究纳入111例低级别胶质瘤患者,基于多参数MRI提取250个影像组学特征构建列线图,用于预测IDH突变和ATRX缺失。列线图在训练集和验证集中均表现出良好的区分度和校准度,决策曲线分析证实其临床实用性。

要点

  • 基于T2 FLAIR、增强T1WI、ASL-CBF、DWI-ADC及eADC提取的影像组学特征联合年龄、性别构建列线图。
  • 列线图预测IDH突变的C-index训练集0.881、验证集0.900;预测ATRX缺失的C-index训练集0.863、验证集0.840。
  • 决策曲线分析证实两种列线图预测IDH和ATRX状态具有临床实用性。

核心结论

  • 整合年龄、性别和影像组学特征的列线图可无创预测低级别胶质瘤患者的IDH和ATRX突变状态,有助于基于MRI的临床决策。

研究设计与样本

  • 回顾性纳入111例低级别胶质瘤患者(IDH突变76例、IDH野生型35例),分为训练集78例和验证集33例预测IDH突变;IDH突变患者进一步分为ATRX缺失38例和ATRX阳性38例。从T2 FLAIR、增强T1WI、ASL-CBF、DWI-ADC和eADC的感兴趣区提取250个影像组学特征,采用弹性网络回归模型筛选影像组学标签,联合年龄、性别构建列线图。

诊断标准与关键数值

  • 列线图预测IDH突变的C-index:训练集0.881、验证集0.900;预测ATRX缺失的C-index:训练集0.863、验证集0.840。

临床应用与阅片要点

  • 作者认为,所提出的列线图方法可促进低级别胶质瘤患者基于MRI的临床决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To construct a radiomics nomogram based on multiparametric MRI data for predicting isocitrate dehydrogenase 1 mutation (IDH +) and loss of nuclear alpha thalassemia/mental retardation syndrome X-linked expression (ATRX -) in patients with lower-grade gliomas (LrGG; World Health Organization [WHO] 2016 grades II and III).

METHODS: A total of 111 LrGG patients (76 mutated IDH and 35 wild-type IDH) were enrolled, divided into a training set (n = 78) and a validation set (n = 33) for predicting IDH mutation. IDH + LrGG patients were further stratified into the ATRX - (n = 38) and ATRX + (n = 38) subtypes. A total of 250 radiomics features were extracted from the region of interest of each tumor, including that from T2 fluid-attenuated inversion recovery (T2 FLAIR), contrast-enhanced T1 WI, ASL-derived cerebral blood flow (CBF), DWI-derived ADC, and exponential ADC (eADC). A radiomics signature was selected using the Elastic Net regression model, and a radiomics nomogram was finally constructed using the age, gender information, and above features.

RESULTS: The radiomics nomogram identified LrGG patients for IDH mutation (C-index: training sets = 0.881, validation sets = 0.900) and ATRX loss (C-index: training sets = 0.863, validation sets = 0.840) with good calibration. Decision curve analysis further confirmed the clinical usefulness of the two nomograms for predicting IDH and ATRX status.

CONCLUSIONS: The nomogram incorporating age, gender, and the radiomics signature provided a clinically useful approach in noninvasively predicting IDH and ATRX mutation status for LrGG patients. The proposed method could facilitate MRI-based clinical decision-making for the LrGG patients.

KEY POINTS: • Non-invasive determination of IDH and ATRX gene status of LrGG patients can be obtained with a radiomics nomogram. • The proposed nomogram is constructed by radiomics signature selected from 250 radiomics features, combined with age and gender. • The proposed radiomics nomogram exhibited good calibration and discrimination for IDH and ATRX gene mutation stratification of LrGG patients in both training and validation sets.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Wu, Zhang, Rui, et al. A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas. Eur Radiol. 2022. PMID: 35133485. doi:10.1007/s00330-021-08444-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。